Activated Protein C Resistance Testing: An Update From Australasia/Asia‐Pacific
International Journal of Laboratory Hematology · 2025
DOI: 10.1111/ijlh.14447 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Laboratory Hematology, 2025. Verfasst von Emmanuel J Favaloro und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Haematology, Sydney Centres for Thrombosis and Haemostasis, Institute of Clinical Pathology and Medical Research (ICPMR), NSW Health Pa…. Hauptthemen laut MEDLINE: Activated Protein C Resistance. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Activated protein C resistance ( APCR ) represents a risk factor for thrombosis and is usually due to factor V Leiden ( FVL ). Clinicians may order either test (i.e., APCR or FVL ) to help assess ‘thrombophilia’ in patients who present with thrombosis. APCR testing is usually achieved using clot‐based assays, whereas FVL is assessed by genetic testing. There are advantages and disadvantages to either approach.
Methods
We report updated findings for APCR testing in our geographic region, in part using recent data from the RCPAQAP, an international external quality assessment (EQA) program, with some 50–60 participants for APCR testing over the past decade. Data have been updated to cover the past 13 years (2010–2023 inclusive), with four samples assessed each year, but with a primary focus on new data from 2020 to 2023 inclusive. In addition, data for APCR testing over several years from four large tertiary‐level hospital laboratories have been assessed following a recent change in instrumentation and haemostasis methods.
Results
EQA data continue to show variable performance in both numerical values and their interpretation for APCR testing, with certain methods providing more consistently correct findings than others. In addition, participant interpretation of their own numerical values and transcription errors seem problematic. Finally, the change in recent laboratory testing has also evidenced local improvements.
Conclusion
APCR assays and testing laboratories continue to show variability in performance, with two methods (Pefakit and Staclot) showing the best performance overall. Targeted education may be of benefit, as most of the errors appear to originate from a small proportion of laboratories.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Haematology, Sydney Centres for Thrombosis and Haemostasis, Institute of Clinical Pathology and Medical Research (ICPMR), NSW Health Pathology, Westmead Hospital, Westmead, New South Wales, Australia.
- Faculty of Science and Health, Charles Sturt University, Wagga Wagga, New South Wales, Australia.
- School of Medical Sciences, Faculty of Medicine and Health, University of Sydney, Westmead Hospital, Westmead, New South Wales, Australia.
- RCPAQAP Haematology, St Leonards, New South Wales, Australia.
- Department of Haematology, NSW Health Pathology, St George Hospital, Kogarah, New South Wales, Australia.
- Department of Haematology, NSW Health Pathology, Royal North Shore Hospital, St Leonards, New South Wales, Australia.
ORCID-Profile: Emmanuel J Favaloro, Leonardo Pasalic
Zitieren
APA
Favaloro, E. J., Arunachalam, S., Dean, E., Salwa, M., Ahuja, M., Connelly, L., Chapman, K., Vong, R., & Pasalic, L. (2025). Activated Protein C Resistance Testing: An Update From Australasia/Asia‐Pacific. International Journal of Laboratory Hematology. https://doi.org/10.1111/ijlh.14447
Vancouver
Favaloro EJ, Arunachalam S, Dean E, Salwa M, Ahuja M, Connelly L, et al. Activated Protein C Resistance Testing: An Update From Australasia/Asia‐Pacific. International Journal of Laboratory Hematology. 2025. doi:10.1111/ijlh.14447
BibTeX
@article{Favaloro2025,
author = {Favaloro, Emmanuel J and Arunachalam, Sandya and Dean, Elysse and Salwa, Mahzuza and Ahuja, Monica and Connelly, Lynne and Chapman, Kent and Vong, Ronny and Pasalic, Leonardo},
title = {Activated Protein C Resistance Testing: An Update From Australasia/Asia‐Pacific},
journal = {International Journal of Laboratory Hematology},
year = {2025},
doi = {10.1111/ijlh.14447}
}
EUVIMED